U.S. Overdose Deaths Fell 17% in Just One Year
By Dennis Thompson HealthDay Reporter
FRIDAY, Dec. 13, 2024 -- In news that suggest the U.S. opioid epidemic may be easing, drug overdose deaths fell 17% between July 2023 and July 2024.
Per new data released Wednesday by the U.S. Centers for Disease Control and Prevention, about 94,000 people died from drug overdoses (ODs) during that 12-month period, down from more than 113,000 deaths between July 2022 and July 2023.
The data represents “the largest recorded reduction in overdose deaths, ever, and this is no coincidence,” Neera Tanden, director of the White House Domestic Policy Council, told STAT.
Efforts to distribute the OD reversal drug naloxone account for much of this decline, White House officials said.
As many as 500,000 overdoses have been reversed in the United States, thanks to the medication, they added.
Naloxone is now available over-the-counter, and is often handed out with prescriptions for opioid painkillers.
"A soldier or a trauma doc will tell you the very first thing you need to do is to [stop] the bleeding," Dr. Rahul Gupta, from the White House Office of National Drug Control Police, told CBS News. "If you don't do that, nothing else matters. We cannot treat dead people."
Policies to make addiction treatment more accessible also contributed to the decline in overdose deaths, as well as strategies to help drug users protect themselves like test strips to detect fentanyl added to illicit narcotics, White House officials said.
The White House also credited efforts to crack down on drug production, including cooperation with China to halt the flow of precursor chemicals used to make fentanyl.
"For far too many years, drug traffickers counted their money while we counted our debt. And we needed to turn that around. We needed to understand that this is a global business, and we need to treat it like one," Gupta said.
Opioids continue to account for most drug ODs, causing nearly 68,000 deaths between July 2023 and July 2024, CDC estimates show.
North Carolina experienced the greatest reduction in fatal ODs during that 12-month period, with deaths declining nearly 36%.
Other states that saw OD deaths decline the most include Virginia (29%), Ohio (27%), Delaware (25%), Nebraska (24%), Pennsylvania (24%), South Carolina (23%), Wisconsin (23%) and West Virginia (23%).
However, OD deaths continued to increase in some states. Alaska experienced a 40% increase in fatal overdoses, along with Utah (10%), Oregon (5%) and Washington (2%).
“The colossal drop in overdose deaths is undoubtedly cause for optimism, but not necessarily for celebration,” Andrew Kessler, the founder of Slingshot Solutions, a Washington-based consulting firm that specializes in addiction and mental health issues, told STAT.
“The Biden administration has certainly been aggressive in its approach to this issue, yet still even more needs to be done,” he added.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-13 06:00
Read more

- STI Testing at Home? Survey Finds Many Young People Are For It
- Higher Traffic-Related Air Pollution Exposure Tied to Depression
- Temperature Exposure Linked to Adolescent Psychiatric Symptoms
- U.S. FDA Approves Expanded Label for Astellas' Izervay (avacincaptad pegol intravitreal solution) for Geographic Atrophy
- FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025
- Federal Judge Rules FDA, CDC Must Restore Health Websites Removed Under Trump Order
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions